Prevent Alzheimers Disease 2020

Organization Overview

Prevent Alzheimers Disease 2020, operating under the name Campaign to Prevent Alzheimers Disease, is located in Rockville, MD. The organization was established in 2009. According to its NTEE Classification (H83) the organization is classified as: Alzheimers Disease Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Campaign to Prevent Alzheimers Disease is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2022, Campaign to Prevent Alzheimers Disease generated $631.4k in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 36.9% each year . All expenses for the organization totaled $521.2k during the year ending 12/2022. While expenses have increased by 30.9% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2022

Describe the Organization's Mission:

Part 3 - Line 1

PAD2020 AIMS TO UNITE THE NATION TOWARDS INCREASING RESEARCH AND KNOWLEDGE TO PREVENT ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES THAT AFFECT MEMORY MOVEMENT OR MOOD.

Describe the Organization's Program Activity:

Part 3 - Line 4a

IN THE UNITED STATES TWO MAJOR REGULATORY HURDLES MUST BE OVERCOME FOR AFFORDABLE AND ACCESSIBLE TOOLS TO BE DEVELOPED AND DEPLOYED FOR DIAGNOSING ASSESSING AND MONITORING THOSE AT RISK OF OR WITH COGNITIVE DISORDERS. THE FDA AND CMS HAVE TWO DIFFERENT REGULATORY MISSIONS. DEVELOPERS OF NEW CLINICAL INTERVENTIONS AND TOOLS MUST DEMONSTRATE THE EFFECTIVENESS AND CLINICAL RELEVANCE OF THEIR OUTCOMES. THEY ALSO NEED TO CONSIDER FACTORS SUCH AS REIMBURSEMENT AND QUALITY. TO ADDRESS THESE CHALLENGES THE CAMPAIGN TO PREVENT ALZHEIMER'S DISEASE LAUNCHED A TASK FORCE TO REVIEW RECOMMENDATIONS AND DEVELOP NEW PROJECT PROPOSALS. THE GROUP TITLED "THE CAMPAIGN TO PREVENT ALZHEIMER'S DISEASE WORK GROUP ON COMMUNITY-BASED DETECTION AND ASSESSMENT OF COGNITIVE DECLINE," IDENTIFIED DIFFERENT PATHWAYS OF COMMUNITY-BASED DETECTION USING ELECTRONIC HEALTH RECORDS FROM DIFFERENT INTERNATIONAL HEALTHCARE SYSTEMS TO DETECT AND MONITOR INDIVIDUALS WITH EARLY COGNITIVE IMPAIRMENT. THE RECOMMENDATIONS AIM TO GUIDE FUTURE SUSTAINABILITY ACTIVITIES PUBLIC POLICY CAMPAIGNS AND IMPLEMENTATION PILOTS.


ALZHEIMER'S DISEASE POSES A SIGNIFICANT BURDEN ON A GLOBAL SCALE WHICH HAS LED TO AN ENORMOUS INVESTMENT IN RESEARCH TO FIND A CURE. HOWEVER DESPITE THESE EFFORTS THERE ARE VERY FEW MEDICATIONS AVAILABLE FOR PEOPLE WITH DEMENTIA. THE SEARCH FOR NEW INTERVENTIONS FOR ALZHEIMER'S DISEASE IS CHALLENGING BECAUSE THE EXACT RELATIONSHIP BETWEEN THE SYMPTOMS OF THE DISEASE AND ITS NEUROBIOLOGY IS NOT YET FULLY UNDERSTOOD. THE DISEASE'S HETEROGENEITY COMPLEX BIOLOGICAL AND ENVIRONMENTAL INTERACTIONS MULTIPLE NONLINEAR TIMESCALES AND A LACK OF MODELING SYSTEMS TO INTEGRATE COMPLEX RELATIONSHIPS FURTHER COMPLICATE THIS EFFORT. TO ADDRESS THESE CHALLENGES THE CALCIUM SYSTEM THEORY OF ALZHEIMER'S DISEASE CAST-AD WORKGROUP AIMS TO DESIGN A UNIFIED SYSTEMS THEORY. THE GROUP AIMS TO CREATE NEW FOUNDATIONAL MODELS TO STUDY PROTEIN DYNAMICS AND AGGREGATION IN NEURODEGENERATIVE DISEASES. THESE MODELS WILL BE TRAINED USING SUPERCOMPUTING AND HYBRID SUPER- AND QUANTUM-COMPUTING TO SIMULATE LARGE DATA SETS OF PROTEINS. THE PROJECT WILL ESTABLISH AND VALIDATE FOUNDATIONAL MODELS USING PROTEINS SUCH AS BIOLUMINESCENT ENZYMES TO PROVIDE AN EASY FUNCTIONAL READOUT. THE GROUP WILL THEN APPLY THESE MODELS TO CRUCIAL PROTEINS AND PEPTIDES INVOLVED IN NEURODEGENERATIVE DISEASES.


BRAIN VASCULAR DISEASES ARE LINKED TO THE ONSET OF DEMENTIA. PAD 20 20 COORDINATED A GLOBAL TASK FORCE TO ASSESS THE EFFICACY OF UTILIZING APPROVED VASCULAR HEALTH INTERVENTIONS TO PREVENT OR TREAT DEMENTIA. EVIDENCE SHOWS THAT MODIFYING LIFESTYLE FACTORS SUCH AS PHYSICAL ACTIVITY HEALTHY DIET AND PROPER SODIUM INTAKE CAN IMPROVE VASCULAR HEALTH AND OFFER AN OPPORTUNITY FOR BRAIN HEALTH. THE INITIATIVE AIMS TO IDENTIFY TANGIBLE OPPORTUNITIES TO PROVIDE FINANCIAL OR TECHNICAL RESOURCES TO SUSTAIN MULTI-YEAR ACTIVITIES AND EVALUATE APPROACHES THAT MAY ACCELERATE THE DEVELOPMENT OF NEW INTERVENTIONS. THE PROJECT WILL FOCUS ON DEVELOPING STRATEGIES TO PROVIDE AFFORDABLE ACCESSIBLE AND EQUITABLE DEMENTIA PREVENTION THROUGH WIDELY PRESCRIBED MEDICATIONS FOR VARIOUS VASCULAR AND METABOLIC DISORDERS. THERE IS A CLEAR NEED FOR ROBUST CLINICAL EVIDENCE TO SUPPORT THIS PUBLIC HEALTH APPROACH.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Zaven Khachaturian
Chair President
$0
Ara Khachaturian
Evp Treasurer
$0
Ronald Petersen
Director
$0
Peter Snyder
Director
$0

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$631,438
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$631,438
Total Program Service Revenue$0
Investment income $0
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $631,438

Create an account to unlock the data you need.

or